特一药业：前三季度净利润同比增长985% 中药产品销售收入同比显著增长

Core Insights - The company reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong financial performance [1] Financial Performance - The company achieved an operating revenue of 692 million yuan, representing a year-on-year growth of 51.86% [1] - The net profit attributable to the parent company reached 65.22 million yuan, showing a remarkable year-on-year increase of 985.18% [1] Product Sales - The sales revenue from traditional Chinese medicine products experienced a notable increase compared to the previous year [1]